---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-137162"
form_type: "8-K"
ticker: "RLAY"
cik: "0001812364"
company_name: "Relay Therapeutics, Inc."
filed_at: "2025-06-06T23:59:59+00:00"
generated_at: "2026-05-19T18:32:42.847733+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Relay Therapeutics stockholders elect directors and approve auditor at 2025 annual meeting

## Summary
- Alexis Borisy elected class II director with 80.7M votes for, 43.0M withheld.
- Mark Murcko elected class II director with 79.5M votes for, 44.2M withheld.
- Non-binding advisory vote on executive compensation approved: 69.7M for, 53.9M against.
- Ratification of Ernst & Young as auditor for FY2025 passed with 142.2M votes for.

## SEC filing metadata
- accession: 0001193125-25-137162
- form_type: 8-K
- ticker: RLAY
- cik: 0001812364
- company_name: Relay Therapeutics, Inc.
- filed_at: 2025-06-06T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1812364/000119312525137162/0001193125-25-137162-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1812364/000119312525137162/d48764d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-137162
- JSON: https://secwatch.observer/filing/0001193125-25-137162.json
- Plain text: https://secwatch.observer/filing/0001193125-25-137162.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.